Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2017

May 31, 2017

33625_dirs_2017-05-31_692d6bf6-38d1-4d77-99bd-435f32aa7dcb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2017-05-26

Reporting Person: Lukatch Heath (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-26 Common Stock M 7246 $43.21 Acquired 7246 Direct
2017-05-26 Common Stock S 7246 $88.5682 Disposed 0 Direct
2017-05-30 Common Stock M 1754 $43.21 Acquired 1754 Direct
2017-05-30 Common Stock S 1754 $88.30 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-26 Stock Option (right to buy) $43.21 M 7246 Disposed 2022-10-13 Common Stock (7246) Direct
2017-05-30 Stock Option (right to buy) $43.21 M 1754 Disposed 2022-10-13 Common Stock (1754) Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 7,246 shares sold in the price range of $88.300 to $88.935 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015.